Quantifying the treatment goals of people recently diagnosed with schizophrenia using best-worst scaling.

导出 LinkOut

翻译打印收藏纠错

作者： John Fp,Bridges ^[1] ; Kathleen,Beusterien ^[2] ; Stephan,Heres ^[3] ; Pedro,Such ^[4] ; Joaquín,Sánchez-Covisa ^[5] ; Anna-Greta,Nylander ^[4] ; Elcie,Chan ^[6] ; Anne,de Jong-Laird ^[5]

作者单位： Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. ^[1] Outcomes Research Strategies in Health, Washington DC, USA. ^[2] Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany. ^[3] Global Medical Affairs, H. Lundbeck A/S, Valby, Denmark. ^[4] Medical Department, Otsuka Pharmaceutical Europe Ltd., Wexham, UK. ^[5] HEOR/Market Access, Otsuka Pharmaceutical Europe Ltd., Wexham, UK. ^[6]

关键词 preferences recent-onset schizophrenia treatment goals

DOI 10.2147/PPA.S152870

PMID 29379273

发布时间 2023-11-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览3

Patient preference and adherence

2018年12卷

63-70页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Quantifying the treatment goals of people recently diagnosed with schizophrenia using best-worst scaling.

Patient preference and adherence

相似文献

Patient preference and adherence

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Quantifying the treatment goals of people recently diagnosed with schizophrenia using best-worst scaling.

Patient preference and adherence

相似文献

Patient preference and adherence

相关期刊

检索历史清除